Placentrex

Placentrex

Price from 46.44 $
Product dosage: 20g
Package (num)Per tubePriceBuy
3$15.48$46.44 (0%)🛒 Add to cart
4$15.05$61.92 $60.20 (3%)🛒 Add to cart
5$14.62$77.40 $73.10 (6%)🛒 Add to cart
6$14.19$92.88 $85.14 (8%)🛒 Add to cart
7$13.88$108.36 $97.18 (10%)🛒 Add to cart
8$13.54$123.84 $108.36 (12%)🛒 Add to cart
9$13.19$139.32 $118.68 (15%)🛒 Add to cart
10
$12.81 Best per tube
$154.80 $128.14 (17%)🛒 Add to cart

Placentrex: Advanced Wound Healing and Tissue Regeneration Therapy

Placentrex is a biological therapeutic agent derived from human placental extract, designed to accelerate wound healing, reduce inflammation, and promote tissue regeneration. It is widely utilized in medical practice for its regenerative and reparative properties, offering a scientifically-backed approach to managing a variety of clinical conditions involving tissue damage, chronic ulcers, and inflammatory disorders. Supported by clinical research and decades of expert use, Placentrex represents a sophisticated option in regenerative medicine, providing targeted therapeutic benefits with a favorable safety profile.

Features

  • Contains biologically active components from human placental extract
  • Available in injectable (intramuscular, subcutaneous, intralesional) and topical gel formulations
  • Standardized extraction and purification process ensuring batch consistency
  • Free from synthetic additives or preservatives in its pure form
  • Supported by pharmacological studies demonstrating anti-inflammatory, angiogenic, and immunomodulatory actions

Benefits

  • Accelerates wound closure and epithelialization in acute and chronic wounds
  • Reduces inflammation and associated pain at the site of injury or pathology
  • Enhances granulation tissue formation and improves local microcirculation
  • Supports functional recovery in nerve injuries and musculoskeletal conditions
  • Minimizes scar formation and improves cosmetic outcomes in healing tissues
  • Provides a holistic therapeutic option with multimodal mechanisms of action

Common use

Placentrex is commonly employed in the management of non-healing wounds such as diabetic foot ulcers, venous stasis ulcers, and pressure sores. It is also indicated in conditions like osteoarthritis, peripheral neuropathy, pelvic inflammatory disease, and post-surgical healing support. Dermatological applications include the treatment of burns, hypertrophic scars, and certain types of dermatitis. Its use is often integrated into comprehensive treatment plans alongside conventional wound care, physical therapy, or pharmacological management.

Dosage and direction

Dosage varies based on formulation, route of administration, and clinical indication. For intramuscular injection, the typical adult dose is 2 mL daily or on alternate days, often for 2–4 weeks depending on therapeutic response. Intralesional administration may involve 0.5–1 mL per injection site, repeated weekly. Topical gel should be applied thinly over the affected area 2–3 times daily. Administration should be performed under aseptic conditions. Dosage adjustments may be necessary based on patient response, severity of condition, and physician discretion.

Precautions

Placentrex should be administered under medical supervision. Avoid use in patients with known hypersensitivity to any component of the formulation. Use with caution in patients with compromised immune function. Topical application should be avoided on infected wounds unless accompanied by appropriate antimicrobial therapy. Pregnancy and lactation data are limited; use only if clearly indicated. Store as directed and do not use beyond the expiration date.

Contraindications

Placentrex is contraindicated in patients with a history of anaphylaxis or severe allergic reactions to placental extract or any constituent of the formulation. It should not be administered to patients with active systemic infections or febrile illnesses unless benefits outweigh risks. Avoid use in malignancies at the site of application or injection unless part of an approved adjunct therapy protocol.

Possible side effect

Most adverse reactions are mild and transient. These may include localized pain, erythema, or swelling at the injection site. Topical application may occasionally cause itching, redness, or mild dermatitis. Systemic reactions such as fever, malaise, or allergic manifestations are rare. Discontinuation of therapy typically leads to resolution of symptoms. Patients should report any persistent or severe reactions to their healthcare provider.

Drug interaction

No significant drug interactions have been conclusively documented. However, as with any biological product, potential interactions with immunosuppressive agents, anticoagulants, or other biologics cannot be entirely ruled out. Concurrent use with topical corticosteroids or anti-infective agents is common in clinical practice and generally well-tolerated. Always inform the prescribing physician of all concomitant medications.

Missed dose

If a dose is missed, it should be administered as soon as remembered unless it is almost time for the next scheduled dose. In that case, resume the regular dosing schedule. Do not double the dose to make up for a missed one. Consistency in application or injection supports optimal therapeutic outcomes.

Overdose

There are no well-documented cases of Placentrex overdose. Excessive application or injection may increase the risk of local reactions. In the event of suspected overdose, discontinue use and seek medical attention. Symptomatic and supportive measures should be employed as necessary.

Storage

Store between 2–8°C (36–46°F). Do not freeze. Protect from light. Keep the vial or tube tightly closed when not in use. Do not use if the solution appears cloudy, discolored, or contains particulate matter. Follow storage instructions specific to the manufacturer’s packaging.

Disclaimer

This information is intended for medical professionals and should not replace clinical judgment. Always adhere to local prescribing guidelines and regulatory approvals. Use only under the direction of a qualified healthcare provider. Efficacy and safety data are based on available clinical evidence; individual patient responses may vary.

Reviews

Placentrex is regarded favorably in clinical settings for its efficacy in challenging wound healing scenarios. Physicians report improved healing rates, reduced patient discomfort, and decreased reliance on antibiotics in many cases. Clinical studies and meta-analyses support its role in enhancing tissue repair, though further large-scale trials are encouraged. Patient satisfaction is often high, particularly in cases where conventional treatments have yielded suboptimal results.